Anisha Ambady

Author PubWeight™ 6.71^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Azaindoles: noncovalent DprE1 inhibitors from scaffold morphing efforts, kill Mycobacterium tuberculosis and are efficacious in vivo.	J Med Chem	2013	0.97
2	Discovery of pyrazolopyridones as a novel class of noncovalent DprE1 inhibitor with potent anti-mycobacterial activity.	J Med Chem	2014	0.89
3	Methyl-thiazoles: a novel mode of inhibition with the potential to develop novel inhibitors targeting InhA in Mycobacterium tuberculosis.	J Med Chem	2013	0.88
4	Essentiality and functional analysis of type I and type III pantothenate kinases of Mycobacterium tuberculosis.	Microbiology	2010	0.83
5	4-aminoquinolone piperidine amides: noncovalent inhibitors of DprE1 with long residence time and potent antimycobacterial activity.	J Med Chem	2014	0.82
6	Lead optimization of 1,4-azaindoles as antimycobacterial agents.	J Med Chem	2014	0.82
7	Pyrazolopyrimidines establish MurC as a vulnerable target in Pseudomonas aeruginosa and Escherichia coli.	ACS Chem Biol	2014	0.77
8	Diarylthiazole: an antimycobacterial scaffold potentially targeting PrrB-PrrA two-component system.	J Med Chem	2014	0.77